We are live on ! Find out more
VTRS icon

Viatris

520 hedge funds and large institutions have $15.5B invested in Viatris in 2018 Q2 according to their latest regulatory filings, with 61 funds opening new positions, 200 increasing their positions, 173 reducing their positions, and 66 closing their positions.

New
Increased
Maintained
Reduced
Closed

16% more repeat investments, than reductions

Existing positions increased: 200 | Existing positions reduced: 173

0% more funds holding in top 10

Funds holding in top 10: 2020 (0)

4% less call options, than puts

Call options by funds: $301M | Put options by funds: $314M

8% less first-time investments, than exits

New positions opened: 61 | Existing positions closed: 66

1.17% less ownership

Funds ownership: 84.98%83.81% (-1.2%)

2% less funds holding

Funds holding: 530520 (-10)

14% less capital invested

Capital invested by funds: $18.1B → $15.5B (-$2.53B)

Holders
520
Holders Change
-10
Holders Change %
-1.89%
% of All Funds
11.9%
Holding in Top 10
20
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.46%
New
61
Increased
200
Reduced
173
Closed
66
Calls
$301M
Puts
$314M
Net Calls
-$13.3M
Net Calls Change
-$162M
Name Holding Trade Value Shares
Change
Change in
Stake
BG
101
Bellevue Group
Switzerland
$18.2M +$10.5M +268,400 +115%
BNP Paribas Financial Markets
102
BNP Paribas Financial Markets
France
$18.1M +$7.82M +199,445 +66%
PP
103
PDT Partners
New York
$17.6M
Susquehanna International Group
104
Susquehanna International Group
Pennsylvania
$17M +$13.8M +352,056 +296%
Chevy Chase Trust
105
Chevy Chase Trust
Maryland
$15.7M -$56.7K -1,446 -0.3%
NC
106
Nexthera Capital
New York
$15.6M +$6.71M +171,009 +66%
PCMK
107
Paragon Capital Management (Kansas)
Kansas
$14.8M +$7.03M +179,177 +2,915%
Retirement Systems of Alabama
108
Retirement Systems of Alabama
Alabama
$14.1M +$5.69M +145,013 +59%
Toronto Dominion Bank
109
Toronto Dominion Bank
Ontario, Canada
$13.3M +$3.74M +95,434 +35%
Ameriprise
110
Ameriprise
Minnesota
$13.3M +$1.37M +34,806 +10%
Macquarie Group
111
Macquarie Group
Australia
$12.5M +$623K +15,884 +5%
Assenagon Asset Management
112
Assenagon Asset Management
Luxembourg
$12.3M +$5.75M +146,686 +76%
Cohen & Steers
113
Cohen & Steers
New York
$12.2M +$2.36M +60,191 +22%
CWG
114
C WorldWide Group
Denmark
$11.9M +$2.1M +53,642 +19%
TAF
115
Tredje AP-fonden
Sweden
$11.6M +$1.46M +37,151 +13%
VanEck Associates
116
VanEck Associates
New York
$11.4M +$1.78M +45,277 +17%
HAM
117
Harber Asset Management
North Carolina
$11.3M +$2.8M +71,356 +30%
Bank of Montreal
118
Bank of Montreal
Ontario, Canada
$11.2M -$32.5M -827,863 -73%
PAM
119
Panagora Asset Management
Massachusetts
$11.2M +$9M +229,496 +286%
Squarepoint
120
Squarepoint
New York
$10.9M +$11M +279,280 +1,271%
HI
121
HBK Investments
Texas
$10.7M +$5.59M +142,400 +93%
Thrivent Financial for Lutherans
122
Thrivent Financial for Lutherans
Minnesota
$10.3M -$28.9K -737 -0.3%
State of New Jersey Common Pension Fund D
123
State of New Jersey Common Pension Fund D
New Jersey
$10.1M +$1.37M +35,000 +14%
Aviva
124
Aviva
United Kingdom
$9.58M -$292K -7,438 -3%
RJA
125
Raymond James & Associates
Florida
$9.15M -$2.32M -59,176 -19%

VTRS Hedge Fund Activity: Q2 2018 in Review

520 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Viatris (VTRS) for Q2 2018, worth a combined $15.5B — down 14% from $18.1B a quarter earlier.

Sellers outnumbered buyers: 66 funds closed out of VTRS and 61 opened new positions — a net loss of 5 holders — while 173 trimmed existing stakes and 200 added.

The largest buyer was Capital World Investors, opening a new position worth an estimated $301M. The largest seller was Goldman Sachs, cutting an estimated $432M.

  • 520 institutional investors held Viatris (VTRS) as of Q2 2018, down from 530 in Q1 2018.
  • Funds reported $15.5B of Viatris stock for Q2 2018, down 14% quarter-over-quarter.
  • 61 funds opened new Viatris positions in Q2 2018 and 66 closed out, a net change of -5 holders.
  • The largest Viatris buyer in Q2 2018 was Capital World Investors, an estimated $301M added.
  • The largest Viatris seller in Q2 2018 was Goldman Sachs, an estimated $432M sold.

Based on aggregated 13F filings for Q2 2018.